Product Information
TRESIBA FLEXTOUCH 200 UNIT/ML is a brand product labeled by Novo Nordisk, priced at $18.0712 per ML under NDC 00169255013. Its NADAC has been published 536 times since Mar 23, 2016.
Strength
200 U/mL
Manufacturer
Novo NordiskNDC
00169255013
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN DEGLUDECApproval Type
Biologic (BLA)
FDA Application
BLA203314On Market Since
9/25/2015
Pharmacological Classes
Price Statistics
The NADAC for TRESIBA FLEXTOUCH 200 UNIT/ML has been published 536 times since Mar 23, 2016, and over the history we have for it it has declined 67.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.0712 per ML |
|---|---|
| All-time high | $65.1977 (Oct 16, 2019) |
| All-time low | $18.0712 (Jun 17, 2026) |
| 52-week high | $65.0575 |
| 52-week low | $18.0712 |
| Median price | $65.0324 |
| Average price | $61.0937 |
| Largest weekly change | -72.2% (Jan 14, 2026) |
| Weeks tracked | 536 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRESIBA FLEXTOUCH 200 UNIT/ML?
The current National Average Drug Acquisition Cost (NADAC) for TRESIBA FLEXTOUCH 200 UNIT/ML, manufactured by Novo Nordisk, is $18.0712 per ML (NDC 00169255013), effective Jun 24, 2026.
How has the price of TRESIBA FLEXTOUCH 200 UNIT/ML changed over time?
Over the history we have for it, the NADAC for TRESIBA FLEXTOUCH 200 UNIT/ML has declined 67.4%. It has been tracked across 536 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for TRESIBA FLEXTOUCH 200 UNIT/ML?
Since Mar 23, 2016, the NADAC for TRESIBA FLEXTOUCH 200 UNIT/ML has ranged from a low of $18.0712 (Jun 17, 2026) to a high of $65.1977 (Oct 16, 2019), with a median of $65.0324 per ML.
Are there cheaper alternatives to TRESIBA FLEXTOUCH 200 UNIT/ML?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TRESIBA FLEXTOUCH 200 UNIT/ML, but none are currently priced below it.
Who manufactures TRESIBA FLEXTOUCH 200 UNIT/ML?
TRESIBA FLEXTOUCH 200 UNIT/ML (NDC 00169255013) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification